Publication: Prevalence of strongyloides in northern Thailand and treatment with ivermectin vs albendazole
Issued Date
2005-03-01
Resource Type
ISSN
01251562
Other identifier(s)
2-s2.0-20444468861
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Southeast Asian Journal of Tropical Medicine and Public Health. Vol.36, No.2 (2005), 442-444
Suggested Citation
Ponganant Nontasut, Chatree Muennoo, Surapol Sa-nguankiat, Sutep Fongsri, Adulsak Vichit Prevalence of strongyloides in northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian Journal of Tropical Medicine and Public Health. Vol.36, No.2 (2005), 442-444. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/17057
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Prevalence of strongyloides in northern Thailand and treatment with ivermectin vs albendazole
Other Contributor(s)
Abstract
The stools of 697 cases were examined by agar plate technique at Tambon Makam Luang, Sun Pa Tong district, Chiang Mai; there were Strongyloides stercoralis 15.9%, Opisthorchis viverrini 5.1%, intestinal fluke 0.1%. Treatment with ivermectin 78 cases and albendazole 33 cases of strongyloidiasis gave cure rates at 98.7% and 78.7%, respectively. Alkaline phosphatase in some patients were increased at mild level after treatment. Side effects in ivermectin group were anorexia, nausia, diarrhea, diffuse itching and drowsiness; and in albendazole group were nausia and diarrhea. The efficacy of single dose and mild side effects suggest ivermectin as drug of choice for strongyloidiasis treatment.